Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction
AUTHORS
Vanderburgh
JJoseph ,
Hill
JLJordan L ,
Gupta
MKMukesh K ,
Kwakwa
KAKristin A ,
Wang
SKSean K ,
Moyer
KKathleen ,
Bedingfield
SKSean K ,
Merkel
ARAlyssa R ,
d'Arcy
RRichard ,
Guelcher
SAScott A ,
Rhoades
JAJulie A ,
Duvall
CLCraig L .
ACS nano. 2020 1 8; 14(1).
311-327
- PMID: 31894963[PubMed].